Company Overview and News

to your dashboard

Headline News

Healthcare: The 'Week That Was' Was Good

4h seekingalpha
Last month, I  explained my rationale for expecting favorable performance from healthcare stocks in January. In biopharmaceuticals, I highlighted Juno Therapeutics, bluebird bio, Madrigal, Arbutus, Conatus  and DURECT, among others. (151-0)

5 Reasons Why McKesson Deserves a Place in Your Portfolio

8h zacks
McKesson Corporation (MCK - Free Report) is a name to reckon with in the current MedTech space as a top-performing stock. Improvement in price performance and strong fundamentals indicate bullish run. If investors haven’t yet taken advantage of the stock’s share price appreciation, it’s time they add it to their portfolio for good returns. (11-0)

5 Reasons Why You Should Offload Wright Medical Stock Now

8h zacks
Wright Medical Group N.V. (WMGI - Free Report) has been having a dismal run on the bourses of late. Over the last three months, the stock has lost 12.3%, underperforming the broader industry’s gain of 9%. The current level also lags the S&P 500’s return of 8.9%. (24-0)

Medtronic (MDT) Wins FDA Nod for New Clinician Programmer

8h zacks
Medtronic plc (MDT - Free Report) announced FDA approval of a new clinician programmer for use with the SynchroMed II Intrathecal Drug Delivery system. This is an implantable pump that provides targeted drug delivery for chronic pain and severe spasticity. Notably, targeted drug delivery is considered an alternative to oral treatment for chronic pain and helps in reducing systemic opioid. (29-0)

Bulletproof Investing Performance: Week 7

13h seekingalpha
One of the three hedged portfolios presented in week seven outperformed its expected return, though the others missed theirs by 1.41% and 0.09%, respectively. (207-0)

Cramer reveals JP Morgan Healthcare Conference winners and losers

22h cnbc
Of all the major conferences that kicked off 2018 — from the ICR confab to the tech-laden CES — the J.P. Morgan Healthcare Conference was the most important for CNBC's Jim Cramer. (297-0)

Will Intuitive Surgical (ISRG) Disappoint in Q4 Earnings?

2018-01-16 zacks
Intuitive Surgical Inc.’s (ISRG - Free Report) fourth-quarter 2017 results, scheduled for release on Jan 25, are expected to show steady growth in instruments and accessories revenues — one of the major revenue components. While this could majorly drive earnings in the quarter under review, an expected improvement in revenues at all other segments should help the company generate solid results this season. (68-0)

Medtronic's ITB Therapy Superior to CMM for PSS Reduction

2018-01-16 zacks
Medtronic plc (MDT - Free Report) announced study results showing the superiority of Medtronic ITB (Intrathecal baclofen) Therapy to conventional medical management (CMM) for the reduction of severe post-stroke spasticity (PSS) in adults. Notably, the results from the ‘Spasticity In Stroke-Randomised Study’ (SISTERS) trial were published in the Journal of Neurology, Neurosurgery & Psychiatry (JNNP). (56-0)

Myriad Genetics Fortifies Molecular Diagnostics With FDA Nod

2018-01-16 zacks
Myriad Genetics, Inc. (MYGN - Free Report) recently announced the receipt of FDA approval for BRACAnalysis CDx test for usage as a companion diagnostic with AstraZeneca and Merck’s PARP inhibitor Lynparza (olaparib) in patients with HER2-negative metastatic breast cancer (MBC) and germline BRCA mutation. (53-0)

QIAGEN Partners DiaSorin, Boosts Molecular Diagnostics Arm

2018-01-15 zacks
QIAGEN N.V. (QGEN - Free Report) recently announced the signing of a new collaboration agreement with DiaSorin. Post collaboration, QIAGEN’s QuantiFERON-TB diagnostic test will be available in DiaSorin’s LIAISON portfolio of fully automated analyzers. (18-0)

Henry Schein (HSIC) Buys ABASE, Expands in Animal Health

2018-01-15 zacks
Henry Schein, Inc. (HSIC - Free Report) recently announced the purchase of a 60% stake in veterinary product distributor — ABASE — under certain undisclosed financial terms. Per the company, the deal will drive earnings after 2018. (35-0)

Express Scripts 90-Day Analysis of Opioid Management Positive

2018-01-15 zacks
In an initiative to reduce excessive opioid prescribing, Express Scripts Holding Company (ESRX - Free Report) announced a 90-day analysis of its Advanced Opioid Management program. (30-0)

Baxter (BAX) Launches Arisure Closed System Transfer Device

2018-01-15 zacks
In a bid to promote safe handling of hazardous drugs and maintain medication sterility, Baxter International Inc. (BAX - Free Report) recently announced a distribution agreement for the launch of the Arisure Closed System Transfer device in the United States. The platform prevents contamination of intravenous (IV) medication delivery system during drug preparation. (59-0)

Abbott's (ABT) Diabetes Care Unit Strong on FreeStyle Libre

2018-01-12 zacks
Abbott (ABT - Free Report) has been hogging the limelight for developments in the flagship, sensor-based continuous glucose monitoring (CGM) system — FreeStyle Libre System. (19-0)

Integra LifeSciences Estimates Strong Revenue Figures for Q4

2018-01-12 zacks
Integra LifeSciences Holdings Corporation (IART - Free Report) reported preliminary, unaudited revenues of approximately $365 million for the fourth quarter of 2017, up 40% year over year. The preliminary revenue figure is above the Zacks Consensus Estimate of $352 million. (29-0)

CUSIP: 46120E602